Efficacy of Low-dose Dapagliflozin in Young People with Type 1 Diabetes

OBJECTIVE: Young people with type 1 diabetes are likely to gain body weight and not achieve optimal glycemic control with only high doses of insulin. This study examined the efficacy of the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin as an adjunct-to-insulin therapy in young Japan...

Descripción completa

Detalles Bibliográficos
Autores principales: Urakami, Tatsuhiko, Yoshida, Kei, Suzuki, Junichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908403/
https://www.ncbi.nlm.nih.gov/pubmed/36642532
http://dx.doi.org/10.2169/internalmedicine.9632-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908403/
https://www.ncbi.nlm.nih.gov/pubmed/36642532
http://dx.doi.org/10.2169/internalmedicine.9632-22

Ejemplares similares